• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI SENSIGHT; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI SENSIGHT; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS Back to Search Results
Model Number B3300542M
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Headache (1880); Intracranial Hemorrhage (1891); High Blood Pressure/ Hypertension (1908); Incontinence (1928); Loss of consciousness (2418); Confusion/ Disorientation (2553); Convulsion/Seizure (4406); Insufficient Information (4580)
Event Date 11/12/2021
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the patient was temporarily unresponsive to voice nor eyes as if catatonic.When asked what year he was born in, he was eventually able to answer.This incident lasted about three minutes.About 5 hours later manufacturer representative was informed that patient had another episode and had been confused about the date and said it was 2001.Patient was taken to the emergency room.Additional information was received stating the patient was admitted last night with seizures due to a small cortical bleed.His bleed has been stable on serial cts and measures 3cm x 1.5 cm.He is neurologically intact except for parkinson's disease sxs and he has having incontinence.It was reported that before his hospitalization he was having unresponsive spells, incontinency, and mild headaches.Family member reports taking his bp and he was in the 140 range, but in the er it was 169.He is now in the icu and normotensive and on keppra.He is getting his pd meds.Rep spoke with physician who provided a description of the bleed and its stability on cts done at 1am, 6am, and 9am.He did not know the reason for the extra scan.Stage 2 surgery on wednesday will be determined based on his ct and how patient does.
 
Event Description
Additional information received from the manufacturer¿s representative (rep), which was confirmed with the healthcare provider (hcp), reported the patient had a history of hypertension but it was believed that their blood pressure had been maintained after surgery.The diagnosis was considered a venous infarct which happened during the surgical procedure when the surgeon was opening the dura.The patient was being transferred to a rehabilitation center soon to work on some of their deficits related to the infarct.Some deficits include not being able to feed themselves and incontinence.It was unknown if the confusion was resolved.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENSIGHT
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer (Section G)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key12832711
MDR Text Key280936769
Report Number2649622-2021-22971
Device Sequence Number1
Product Code MHY
UDI-Device Identifier00763000426408
UDI-Public00763000426408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 11/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/07/2023
Device Model NumberB3300542M
Device Catalogue NumberB3300542M
Was Device Available for Evaluation? No
Date Manufacturer Received11/17/2021
Date Device Manufactured10/07/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age66 YR
Patient SexMale
Patient Weight75 KG
-
-